Lisa DeFrancesco | Senior Vice President, Corporate Affairs and Investor Relations |
Jerry Durso | President and Chief Executive Officer |
Linda Richardson | Chief Commercial Officer |
Michelle Berrey | President of Research and Development and Chief Medical Officer |
Andrew Saik | Chief Financial Officer |
Michael Lee | Jefferies |
Alethia Young | Cantor Fitzgerald |
Yasmeen Rahimi | Piper Sandler |
Brian Skorney | Baird |
Brian Abrahams | RBC Capital Markets |
Anvita Gupta | Cowen and Company |
Jay Olson | Oppenheimer |
Steve Seedhouse | Raymond James |
Thomas Smith | SVB Leerink |
Jon Wolleben | JMP Securities |
Good day and thank you for standing by. Welcome to the Second Quarter 2021 Intercept Pharmaceuticals Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation there will be a question-and-answer session. [Operator Instructions] I would now like to hand the call over to your speaker, Lisa DeFrancesco, Senior Vice President, Investor Relations and Corporate Affairs.